Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr-Jun;3(2):122-7.

Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment

Affiliations
Review

Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment

Ingrid Carantino et al. J Med Life. 2010 Apr-Jun.

Abstract

Although the healing means 2 types of biological mechanisms that seem to be "pathologic", the swell and the granulations are a normal process in the biology of the human being, representing two systemic functions: the adaptation and the morphogenesis. There is a pathological healing in which the fundamental healing phenomenon is deviated from the normal. There are three variable parameters responsible for the pathological evolution of a scar: the cellular population, the fundamental matrix and the fibers. The healing evolution can be deviated to an intense maturation with an "old", atrophic scar, or to an incomplete maturation and the result is a hypertrophic or a keloid scar. For the hypertrophic scars, the excision and the skin graft lead to good results and the relapses are rare; the keloid relapse is always at the border between the graft and the wound edge, or between the two skin grafts. These are the considerations for which the treatments are mixed, combined (surgical, drugs, physiotherapy) both in our country and abroad, but the results are still frustrating. That is why new, modern methods of treatment are used today: criotherapy, laser, ultrasounds. However, even those treatments are not very successful: tissue expander, external press therapy, corticosteroids injections, other pharmacological agents (retinoic acid, colchicines, antineoplasics). We propose a regenerative, alternative, non-invasive treatment starting from the results we obtained in a research work 4 years ago, when we irradiated the fibroblasts in an electromagnetic high frequency millimeter waves field, and we obtained the fibroblasts apoptosis and the reorganization of the collagen fibers by changing the piezoelectric emission.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Granulation tissue with inflammatory cells and congested blood vessels; hematoxylin–eosin color (objective 40x)
Figure 2
Figure 2
Keloid with abnormally large collagen fibers and large fibroblasts; hematoxylin–eosin color (objective 40x).The healing evolution can be deviated to an intense maturation with an ‘old’, atrophic scar, or to an incomplete maturation and the result is a hypertrophic or a keloid scar.
Figure 3
Figure 3
Atrophic scar in a 28–year–old man, after losing 20 kg
Figure 4
Figure 4
Retractile scar after a hypertrophic scar, in a 19–year–old girl, operated at 4 years old
Figure 5
Figure 5
Keloid scar after acneea vulgaris
Figure 6
Figure 6
Fascicles of collagen fibers (keloid scar); Philips 206 S electron microscope
Figure 7
Figure 7
Keloid scar–hematoxylin–eosin color, optical microscopy [Novex Holland optical microscope, Carfem Electronic Ltd]

References

    1. Chiotan N, Matusz P, Florescu I. Cicatrizarea. National; 1999.
    1. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997;77:701–730. - PubMed
    1. Hiroshi I, Hirosh Y, Masaki F, Ryuichi M, Akiyoshi H, Tohru F. Keloid Fibroblasts Resist Ceramide–Induced Apoptosis by Overexpression of Insulin–Like Growth Factor Ⅰ Receptor. Journal of Investigative Dermatology . 2000;115:1065–1071. - PubMed
    1. Yoshimoto H, Ishihara H, Ohtsuru A. Overexpression of insulin–like growth factor–Ⅰ (IGF–Ⅰ) receptor and the invasiveness of cultured keloid fibroblasts . Am J Pathol. . 1999;154:883–889. - PMC - PubMed
    1. Badalamente MA, Hurst LG, Grandia SK. Platelet derived growth factor in Dupuytren's disease . Hand. Surg. 1992;17A:317. - PubMed

LinkOut - more resources